Literature DB >> 1863640

Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.

G S Harrison1, F Maxwell, C J Long, C A Rosen, L M Glode, I H Maxwell.   

Abstract

Expression of a gene encoding the diphtheria toxin A (DT-A) fragment, controlled by tissue specific regulatory elements, has previously been used to kill selected cell populations. Here, we have examined the feasibility of controlling DT-A expression using regulatory systems from the human immunodeficiency virus (HIV-1) genome. Plasmids were constructed which express either DT-A or, as a model system, the luciferase (luc) reporter gene, under control of HIV-1 long terminal repeat (LTR) sequences (-167 to +80). While trans-activation by expression of the viral protein Tat was demonstrated, significant basal expression was observed. To reduce basal expression, cis-acting negative regulatory elements from the env region of the HIV-1 genome were inserted in the 3' untranslated region of both the luc and DT-A constructs. This dramatically reduced basal expression from the HIV LTR, and now both viral regulatory proteins Tat and Rev were required for maximal trans-activation. Such regulation of DT-A expression might be therapeutically applied to selectively kill HIV-infected cells in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863640     DOI: 10.1089/hum.1991.2.1-53

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  17 in total

1.  A versatile and reliable two-component system for tissue-specific gene induction in Arabidopsis.

Authors:  Lukas Brand; Mirjam Hörler; Eveline Nüesch; Sara Vassalli; Philippa Barrell; Wei Yang; Richard A Jefferson; Ueli Grossniklaus; Mark D Curtis
Journal:  Plant Physiol       Date:  2006-08       Impact factor: 8.340

2.  Inhibition of human immunodeficiency virus replication by the herpes simplex virus virion host shutoff protein.

Authors:  T Hamouda; R McPhee; S C Hsia; G S Read; T C Holland; S R King
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 3.  A defective HIV-1 vector for gene transfer to human lymphocytes.

Authors:  C Parolin; J Sodroski
Journal:  J Mol Med (Berl)       Date:  1995-06       Impact factor: 4.599

4.  Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells.

Authors:  J W McCarrick; J R Parnes; R H Seong; D Solter; B B Knowles
Journal:  Transgenic Res       Date:  1993-07       Impact factor: 2.788

5.  Human immunodeficiency virus vectors for inducible expression of foreign genes.

Authors:  G L Buchschacher; A T Panganiban
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Selective transduction of HIV-1-infected cells by the combination of HIV and MMLV vectors.

Authors:  Noriyasu Sakai; Koichi Miyake; Noriko Suzuki; Takashi Shimada
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

7.  Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.

Authors:  J Drago; P Padungchaichot; J Y Wong; A J Lawrence; J F McManus; S H Sumarsono; A L Natoli; M Lakso; N Wreford; H Westphal; I Kola; D I Finkelstein
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.

Authors:  Michael Bordonaro; Darina L Lazarova; Alan C Sartorelli
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

9.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.

Authors:  S C Flores; J C Marecki; K P Harper; S K Bose; S K Nelson; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 10.  Modular Cre/lox system and genetic therapeutics for colorectal cancer.

Authors:  Michael Bordonaro
Journal:  J Biomed Biotechnol       Date:  2009-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.